Analysts have been eager to weigh in on the Healthcare sector with new ratings on Evolent Health (EVH – Research Report) and Staar Surgical ...

Morgan Stanley analyst Thibault Boutherin initiated coverage of Novartis (NVS) with an Underweight rating and CHF 91 price target The company ...

This implies a 33% upside from the closing rate of the stock on January 28, 2025. 3 reasons why Nuvama has Buy on TVS Motor Upcycle in two-wheelers: The brokerage house is confident about the ...

Mets have an elite defensive outfielder at their disposal in 2025 Mets taking high-upside risk with former Yankees star closer Mets bracing for harsh divorce with All-Star slugger To navigate ...

A young mother's life dramatically changed after a seemingly insignificant insect bite. Melonie Bray found herself unable to speak, open her eyes or interact with her young daughter, losing ...

But they also have major health benefits, experts say, including antioxidant and anti-inflammatory effects — on top of their high content of fiber, fatty acids, vitamins and minerals.

The San Diego Padres made an intriguing move Friday afternoon, acquiring former Yankees bullpen arm Ron Marinaccio from the Chicago White Sox for cash considerations. At 29 years old, Marinaccio ...

Needham initiates Absci coverage with a Buy rating and a $9 price target, citing robust proprietary technology. Absci’s partnerships with Merck, AstraZeneca, and Almirall provide milestone ...

However, these three companies are ones I think could have among the most impressive upside potential this year, if a variety of catalysts take hold. Each company has their own unique catalysts I ...

BrightSpring Health Services, Inc. BTSG shares rallied 12.6% in the last trading session to close at $20.89. This move can be attributable to notable volume with a higher number of shares being ...